Shana Novak | Stone | Getty Image
President Donald Trump’s steep tariff Some drug trade organizations warned that in Canada, Mexico and China in the United States ‘existing drugs in the United States, improvement of patients’ healthcare costs and threatening cash shorts of cash shortage.
Trump announced on Saturday that he will levy 25 % of tariffs on almost all commodities transported from Canada and Mexico and allegations to China by 10 %, all of which will take effect on Tuesday. Monday, Claudia Sheinbaum Pardo, Claudia Sheinbaum Pardo, said that the United States will Delayed tariffs After Mexico agreed, the country lasted for a month Strengthen security At its boundary.
Trump said that tariffs will be kept in place until the three countries stop Fantne and immigrants without document entering the United States.
But the import tax is because the United States works hard Lares on key drugs From injection of cancer therapy to generic drugs or cheaper brand drugs, these drugs forced hospitals and patients to conduct rational drugs. This is also the cost of many Americans who are working hard.
USA Serious dependence Drugs in other countries, especially generic drugs. Those drugs 90 % In the prescriptions of Americans, tariffs may threaten many patients to obtain a matter of affordable treatment.
In particular, China is a large supplier of active drug components or APIs for brand and general drugs because of the low cost of manufacturing in the country. API is the main component of the drug that causes treatment expectations. Some generic drugs are completely produced overseas.
One item statement John Murphy, CEO of the Pharmaceutical Association, representing General Pharmaceutical Company.
Murphy said on Sunday: “General manufacturers cannot absorb new costs at all.” “Our manufacturers sell at extremely low prices, sometimes losing money, and more and more forced to withdraw from the underwater market.”
He urged the Trump administration to levy imitation drugs for tax -free and added that despite the “increase” and new general drugs, the overall value of all general sales in the United States reduced $ 6.4 billion in five years.
The medical care distribution alliance representing 40 drug distributors also calls on the Trump administration to re -consider drugs including tariffs. The organization stated in a statement on Sunday that tariffs will cause damage to the pharmaceutical supply chain and “may not affect American patients.”
The organization said that tariffs will put additional pressure on industries that are already in financial difficulties, and point out that the low profit margin of the distributor is only 0.3 %.
The Medical Care Distribution Alliance said that the United States may see “new and bad shorts in important drugs”, which will “attribute to the payer and patients, including the payer in the medical insurance and medical subsidy plan.”
one estimate Yale University’s budget laboratory said that after the transfer of US supply chain, the long -term price of American drugs will be 1.1 % higher.
American pharmaceutical research and manufacturers on behalf of the pharmaceutical company said in a statement that it share Trump’s goal to ensure that the United States maintains its “leadership of global biopharmaceutical innovation and manufacturing.”
The organization adds that trade indicators should be concentrated in “solving unfairness abroad and protecting our intellectual property rights.”
Medical equipment
The United States also relies on overseas manufacturing for medical equipment. Many of the key components and finished products come from China, Mexico and India.
For example, Intuitive surgeryProduction robot surgery system, disclose each year Report Last week, the company’s tools and accessories were made in Mexicali, Mexico Mexico.
The company said that the country’s tariffs will “increase the cost of our products we produce in Mexico and have a adverse effect on our gross profit.”
Advamed, the world’s largest medical equipment association, urges the Trump administration to exempt tariffs from tariffs. The organization said in a statement that import tax may lead to the shortage of key medical technology, higher prices of patients and payers, and less investment in R & D.
Advamed said that tariffs and related costs are essentially “practical consumption tax” and pointed out that when Trump imposed tariffs on China during his first term, he provided courage to many medical technology departments.
Tariffs may also affect hospitals. These hospitals depend on the imports of daily necessities, such as dresses, gloves and syringes, and larger items, such as X -ray equipment.
However, the American Medical Warductuctures Association advocates American enterprises to produce medical personal protection equipment or PPE companies, support China’s tariffs and increase domestic production of these products.
The organization said in a statement on Monday that tariffs recognize that China “has not changed its way and continued to engage in anti -competition and dangerous behavior, endangering our PPE and medical supply manufacturers, and threatened our supply chain and country Safety.”
